George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksULS.L Regulatory News (ULS)

  • There is currently no data for ULS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

21 Jul 2020 18:06

RNS Number : 6814T
ULS Technology PLC
21 July 2020
 

 

ULS Technology Plc

 

Directors' Dealings & Holdings in Company

ULS Technology plc (LSE:ULS, "Company" or "ULS") received notification on 21 July 2020 from Kestrel Partners LLP ("Kestrel") that on the 20 July 2020 it purchased for its discretionary clients, 20,000 ordinary shares of 0.4p each ("Shares") in the Company at an average price of £0.585 per share. The notification also included the matters set out below.

Mr Scott, a non-executive director of ULS, is a partner of, and holds a beneficial interest in Kestrel. Mr Scott is also a shareholder in one of Kestrel's clients ("Kestrel Opportunities") and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in ULS.

Following this transaction, Kestrel Opportunities holds (and consequently Mr Scott is deemed to have a beneficial interest in) 11,292,408 Shares in the Company, and other clients of Kestrel, in which Mr Scott has no beneficial interest hold 6,422,736 Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 17,715,144 Shares in the Company, which represents 27.31% per cent of the Company's issued share capital.

Kestrel's interest in the Shares in the Company is held through the following nominees:

 

Holding type

Nominee

No. of shares

% of issued share capital

Indirect

Bank of New York Nominees Ltd

11,292,408

17.41%

Indirect

JIM Nominees Limited

1,178,569

1.82%

Indirect

Bank of New York Nominees Ltd

5,134,067

7.91%

Indirect

Bank of New York Nominees Ltd

110,100

0.17%

 

For further information contact:

 

ULS Technology plc +44 (0) 1844 262392

John Williams, Chief Financial Officer

Steve Goodall, Chief Executive Officer

 

Numis Securities Limited (NOMAD and Broker) +44 (0) 20 7260 1000

Stuart Skinner

Paul Gillam

 

Walbrook PR Limited +44 (0) 20 7933 8780

Tom Cooper

Nick Rome

Nicholas Johnson

 

 

 

 

ANNEX

 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kestrel Partners LLP ('Kestrel')

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PCA - Oliver Rupert Andrew Scott (non-executive director of ULS Technology plc and Partner in Kestrel)

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

ULS Technology plc

b)

 

LEI

 

 

213800TDUOUSIQT2OT29

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

0.4p Ordinary Shares

 

 

 

ISIN: GB00BNG8T458

 

b)

 

Nature of the transaction

 

Purchase

c)

 

Price(s) and volume(s)

 

Purchase:

20 July 2020

Price(s)

 

Volume(s)

GBP 0.585

 

20,000 shares

 

 

 

d)

 

Aggregated information

- Aggregated volume

- Price

 

Total Purchase of 20,000 shares in total at an average of £0.585 per share (total price £11,700.00).

 

 

e)

 

Date of the transaction

 

 20/07/20

f)

 

Place of the transaction

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFIDDSILFII
Date   Source Headline
13th Sep 20211:02 pmRNSDirector/PDMR Shareholding
9th Sep 202111:15 amRNSDirector/PDMR Shareholding
7th Sep 202112:44 pmRNSDirector/PDMR Shareholding
3rd Sep 20211:38 pmRNSDirector/PDMR Shareholding
23rd Aug 20213:26 pmRNSDirector/PDMR Shareholding
20th Aug 20217:00 amRNSDirector/PDMR Shareholding
17th Aug 20212:55 pmRNSDirector/PDMR Shareholding
17th Aug 202110:45 amRNSResult of AGM
17th Aug 20217:00 amRNSAGM Statement
13th Aug 202111:06 amRNSDirector/PDMR Shareholding
12th Aug 20211:17 pmRNSHolding(s) in Company
11th Aug 202111:31 amRNSDirector/PDMR Shareholding
9th Aug 202111:12 amRNSDirector/PDMR Shareholding
9th Aug 20217:00 amRNSULS Recruits Conveyancing Transformation Director
6th Aug 20219:15 amRNSDirector/PDMR Shareholding
3rd Aug 202110:02 amRNSDirector/PDMR Shareholding
30th Jul 202111:51 amRNSDirector/PDMR Shareholding
30th Jul 20217:00 amRNSHolding(s) in Company
29th Jul 20212:54 pmRNSHolding(s) in Company
28th Jul 202112:17 pmRNSDirector/PDMR Shareholding
26th Jul 202112:27 pmRNSDirector/PDMR Shareholding
22nd Jul 202112:55 pmRNSDirector/PDMR Shareholding
22nd Jul 20217:00 amRNSPosting of Annual Report and Notice of AGM
20th Jul 202110:10 amRNSDirector/PDMR Shareholding
16th Jul 202112:26 pmRNSDirector/PDMR Shareholding
15th Jul 20219:07 amRNSDirector/PDMR Shareholding
12th Jul 20217:00 amRNSFinal Results
5th Jul 20217:00 amRNSULS Strengthens Senior Leadership Team
24th Jun 20217:00 amRNSRescheduling of Final Results
7th Jun 20217:00 amRNSNotice of Results & Investor Presentation
28th May 20217:00 amRNSPartnership with MPowered Mortgages
26th May 20212:05 pmRNSDirector/PDMR Shareholding
11th May 20217:00 amRNSTrading Update and Directorate Change
7th May 20214:45 pmRNSHolding(s) in Company
4th May 20215:07 pmRNSDirector/PDMR Shareholding
19th Feb 20217:00 amRNSGrant of Options
18th Feb 20217:00 amRNSDirector Dealings
25th Jan 20217:00 amRNSCommencement of new CEO
21st Jan 20214:57 pmRNSDirector/PDMR Shareholding
19th Jan 20215:25 pmRNSDirector/PDMR Shareholding
18th Jan 20217:00 amRNSDirector/PDMR Shareholding
11th Jan 20215:47 pmRNSDirector/PDMR Shareholding
7th Jan 20215:00 pmRNSDirector/PDMR Shareholding
5th Jan 20215:26 pmRNSDirector/PDMR Shareholding
4th Jan 20217:00 amRNSDirector/PDMR Shareholding
24th Dec 202012:55 pmRNSDirector/PDMR Shareholding
21st Dec 20205:07 pmRNSDirector/PDMR Shareholding
18th Dec 20207:00 amRNSDirector/PDMR Shareholding
17th Dec 20207:00 amRNSPDMR Exercise of Options
16th Dec 20207:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.